Edward Bryan, CFA
17 Years at AB|18 Years of Experience
Edward Bryan is a Portfolio Manager for the Sustainable Global Small Cap Portfolio, and Senior Research Analyst for the Sustainable Thematic Equities team, responsible for covering the global healthcare sector. He began his career at AB in 2007 as an associate in the Institutional Investments division. In 2010, Bryan became a trading desk analyst in the US Equities Trading department. He joined the research team in 2011. Bryan holds a BA in economics from Franklin & Marshall College and is a CFA charterholder. Location: New York
Published Work
Despite conventional wisdom, political uncertainty doesn’t necessarily pose acute risks to the healthcare sector.
Technology and creative research should continue to drive company breakthroughs in medicine and packaging.
ESG ratings are lacking for small-cap stocks globally. This prevents asset managers that rely on third-party ratings from building small-cap funds.
Synthetic biology is not science fiction. Investors should get acquainted with a technology that will create sustainable solutions in many industries.
As the transformational science of synthetic biology makes a growing impact on more industries, equity investors will find exciting opportunities.
Diagnostics - the back-end robotics in the health care system - are helping automate many complex procedures. Diagnostics are not only increasingly aiding the treatment of patients with infectious diseases but accelerating the broader trend toward personalized health care.